CompletedPhase 2NCT02702180
Efficacy and Safety of Inhaled Molgramostim (rhGM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis
Studying Autoimmune pulmonary alveolar proteinosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Savara Inc.
- Principal Investigator
- Cliff Morgan, MD, MDRoyal Brompton Hospital, London
- Intervention
- Molgramostim(drug)
- Enrollment
- 139 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2016 – 2019
Study locations (30)
- UCLA, Los Angeles, California, United States
- University of Florida, Gainesville, Florida, United States
- Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
- Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
- Aarhus University Hospital, Aarhus, Denmark
- CHU Rennes Hospital Pontchaillou, Rennes, France
- Westdeutsches Lungenzentrum am Universitätsklinikum Essen, Essen, Germany
- Asklepios Fachkliniken München - Gauting, Gauting, Germany
- Thoraxklinik am Universitätsklinikum Heidelberg, Heidelberg, Germany
- Universitätsklinikum Schleswig-Holstein Zentralklinikum, Lübeck Medizinische Klinik III, Pneumologie, Lübeck, Germany
- Attikon University Hospital, Athens, Greece
- Rabin Medical Center, Petah Tikva, Israel
- IRCCS Policlinico San Matteo, Pavia, Italy
- Niigata University Medical and Dental Hospital, Niigata, Japan
- National Hospital Organization Kinki-Chuo, Osaka, Japan
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02702180 on ClinicalTrials.govOther trials for Autoimmune pulmonary alveolar proteinosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06431776Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).Savara Inc.
- RECRUITINGPHASE4NCT07200544Meloxicam in Mohs Micrographic SurgeryUniversity of Oklahoma
- RECRUITINGPHASE4NCT07102641Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous TherapiesThomas Jefferson University
- ACTIVE NOT RECRUITINGPHASE2NCT06111846Study of Human Bone Marrow Mesenchymal Stem Cells in APAPJiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
- RECRUITINGPHASE4NCT05425355Intravenous vs Oral Acetaminophen in Postoperative Hip Fracture Adult PatientsUniversity Health Network, Toronto
- ACTIVE NOT RECRUITINGPHASE3NCT04544293Clinical Trial of Inhaled Molgramostim Nebulizer Solution in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)Savara Inc.
- RECRUITINGPHASE4NCT03759028Supracondylar Post-Operative Pain StudyUniversity of California, Los Angeles
See all trials for Autoimmune pulmonary alveolar proteinosis →